Monte Rosa Therapeutics Signs Underwriting Agreement With Jefferies, TD Securities and Piper Sandler
I'm PortAI, I can summarize articles.
Monte Rosa Therapeutics has signed an Underwriting Agreement for a public offering of 11,125,000 shares at $24.00 each and 1,375,000 pre-funded warrants at $23.9999. The underwriters, Jefferies, TD Securities, and Piper Sandler, have a 30-day option to purchase an additional 1,875,000 shares. The company anticipates net proceeds of approximately $281.6 million to support the development of MRT-8102, its QuEEN platform, and other corporate purposes. The agreement was signed on January 8, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments